Galapagos opposes takeover attempt by Gilead

Onno van de Stolpe, CEO of Belgium-based biotech Galapagos, has reported to Belgian daily De Tijd that his company won’t be acquired in the near future by US-based Gilead and will, instead,  remain independent.